CRA I Germany ICON plc is a world-leading healthcare intelligence and clinicalresearch organization. We’re proud... future of clinical development We are currently seeking a ClinicalResearch Associate to join our diverse and dynamic team...
on global study activities; working closely with the project coordinator and clinical trial manager Ensure timely delivery... Overview Medpace is a full-service clinical contract research organization (CRO). We provide Phase I-IV clinical development...
orientation. Project Manager (m/f/d) in ClinicalResearch Location: 60311, Francfort Project Manager (m/f/d) in ClinicalResearch... 3 years of experience in clinicalresearch are mandatory, preferably in combination with experience in project...
orientation. Project Manager (m/f/d) in ClinicalResearch Location: 60311, Francfort Project Manager (m/f/d) in ClinicalResearch... 3 years of experience in clinicalresearch are mandatory, preferably in combination with experience in project...
als Study Nurse, Study Coordinator oder als ClinicalResearch Associate sind von Vorteil aber kein Muss Selbstständigkeit...Einleitung Wir suchen Dich als Klinischer Monitor (ClinicalResearch Associate) & Study Nurse zum nächstmöglichen...
will be perfect for you if: Have experience with patient recruitment programs and strategy Have experience with NA and EU clinical... trials You understand GDPR and EU regulations for clinical trials and you are able to support US/CAN studies...
Overview: Velocity ClinicalResearch is an owned and integrated research site organization, providing excellence in.... Whether you are new to clinicalresearch or are an industry veteran, we invite you to apply to Velocity. Benefits include...
on global study activities; working closely with the project coordinator and clinical trial manager Ensure timely delivery... Overview Medpace is a full-service clinical contract research organization (CRO). We provide Phase I-IV clinical development...
Herzlich Willkommen bei der innovativen & modernen dermatologischen Gemeinschaftspraxis Dres. Quist. Wir sind Spezialisten für Hautmedizin, Ästhetik und Forschung in Mainz und dem Rhein-Main-Gebiet. Neueste medizinische Geräte und kontinu...
ein branchenführendes Unternehmen arbeiten? IQVIA sucht derzeit nach einem/r ClinicalResearchCoordinator / Study Nurse (m... #LI-DNP IQVIA is a leading global provider of clinicalresearch services, commercial insights and healthcare...
The key catalysts for Bandhan Bank stock would be a sustained improvement in asset quality along with clarity about longer tenure for the CEO Continue Reading »
Multibagger stock: Hi-Tech Pipes has launched QIP at a floor price of ₹194.98 apiece, 2060% lower than the current Hi-Tech Pipes share price Continue Reading »
Cellecor Gadgets has partnered with OSIA Hyper Retail to bring its range of appliances and smart gadgets to OSIA Hypermart’s extensive retail network across Gujarat. Continue Reading »
Forty-three companies will have their pre-IPO lock-ins expire between October 8 and December 31, 2024, potentially releasing shares worth $18.8 billion. Some of the prominent names include Bajaj Housing Finance, Ola Electric, Mankind Pharma and PN Gadgil among others. Continue Reading »
Olectra Greentech is poised for growth as demand for electric buses rises. As of March 31, 2024, the company's order book for electric buses stood at 10,969 units, with more tenders anticipated to boost this number. Continue Reading »
SEBI's new rules, set to be implemented in two phases starting October 14, 2024, will enable the direct credit of securities to investors’ demat accounts after a trade, reducing the intermediary role of stockbrokers in the settlement process. Continue Reading »
OK Play India shares rose 5% to ₹13.59 after a promoter raised stake in the company. The board approved the allotment of 1 crore shares to Anandana Handa at ₹6.021 each. Despite a 20% drop in 2024, the stock is up 450% since October 2019. Continue Reading »
Stock market today: According to experts, Nifty Bank Index has outperformed other frontline indices due to these two reasons: better-than-expected Q2FY25 update, and rate cut buzz from RBI MPC meeting Continue Reading »